Kodiak Sciences Inc.
General ticker "KOD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $387.4M (TTM average)
Kodiak Sciences Inc. follows the US Stock Market performance with the rate: 51.8%.
Estimated limits based on current volatility of 3.9%: low 22.09$, high 23.90$
Factors to consider:
- Total employees count: 111 (-0.9%) as of 2023
- Top business risk factors: Product development risks, Market competition, Regulatory and compliance, Manufacturing disruptions, Economic downturns and volatility
- Current price 103.4% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.89$, 12.17$]
- 2025-12-31 to 2026-12-31 estimated range: [2.32$, 7.62$]
Financial Metrics affecting the KOD estimates:
- Negative: with PPE of -2.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -23.35 <= 0.33
- Negative: Industry earnings per price (median), % of -16.34 <= 0
- Positive: Investing cash flow per share per price, % of -0.15 > -0.66
- Positive: 41.86 < Shareholder equity ratio, % of 44.78 <= 63.39
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term KOD quotes
Long-term KOD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $341.38MM | $277.32MM | $186.85MM |
| Operating Income | $-341.38MM | $-277.32MM | $-186.85MM |
| Non-Operating Income | $7.56MM | $16.83MM | $10.64MM |
| Interest Expense | $0.02MM | $0.01MM | $0.00MM |
| R&D Expense | $267.59MM | $206.30MM | $126.09MM |
| Income(Loss) | $-333.82MM | $-260.49MM | $-176.21MM |
| Profit(Loss)* | $-333.82MM | $-260.49MM | $-176.21MM |
| Stockholders Equity | $436.17MM | $265.78MM | $150.29MM |
| Assets | $666.63MM | $479.37MM | $335.58MM |
| Operating Cash Flow | $-206.46MM | $-154.18MM | $-117.32MM |
| Capital expenditure | $47.36MM | $41.43MM | $0.40MM |
| Investing Cash Flow | $-336.51MM | $249.23MM | $-0.76MM |
| Financing Cash Flow | $1.90MM | $0.03MM | $0.50MM |
| Earnings Per Share** | $-6.39 | $-4.97 | $-3.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.